Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / November / Influenza Screening Could a TasteBased Sensor Play a Role / Summary
Microbiology & Immunology Infectious Disease Point of care testing

Influenza Screening: Could a Taste-Based Sensor Play a Role?

Selective methylation of N-acetylneuraminic acid enabled a taste-releasing sensor to distinguish influenza neuraminidase from bacterial enzymes

By Kathryn Wighton 11/25/2025 News 3 min read
article Full Article Summary Notecard

Share

Researchers have developed a novel taste-based influenza screening method utilizing viral neuraminidase activity to activate a chemical sensor. This approach focuses on N-acetylneuraminic acid derivatives connected to thymol, ensuring selectivity for viral neuraminidase. Two sensor variants were created, with the methylated α-linked sensor successfully responding only to viral neuraminidase while maintaining structural stability and cytotoxicity safety. These advancements could enable low-cost, rapid influenza testing, pending further evaluation against patient outcomes.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.